HubSpot
HUBS NYSE Application Software Financials FY2016βFY2025
HubSpot's revenue rose 19.2% to $3.1 billion in fiscal 2025. Its operating margin was 0.2%, up from β2.6% a year earlier. Free cash flow was $708 million, up 26.2%. It paid out $500 million in dividends and buybacks, 71% of free cash flow. The diluted share count rose 2.6%.
About these figures. HubSpot's convertible notes aren't fully tagged in its filings from 2022, so debt is blank from then (it repaid the last notes in 2025).
What HubSpot does
No business description yet.
- Legal name
- HubSpot, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-046646
0001404655
Revenue and margins
HubSpot had $3.1B of revenue in fiscal 2025, up 19.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $708M in fiscal 2025, 22.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
HubSpot returned $500M to shareholders in fiscal 2025, 71% of free cash flow. The diluted share count rose 2.7%.
Value HubSpot yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 53.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 96.4x Β· peers 52.0x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably HubSpot can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.2B | $1.4B | $1.4B | $2.1B | $1.7B |
| Debt incl. finance leases | $403M | β | β | β | β |
| Debt / equity | 0.5x | β | β | β | β |
| Interest coverage | β1.8x | β27.3x | β52.9x | β18.2x | 8.4x |
| Current ratio | 2.4x | 2.3x | 2.0x | 1.7x | 1.7x |
| Quick ratio | 2.4x | 2.3x | 2.0x | 1.7x | 1.7x |
| Total assets | $2.2B | $2.5B | $3.1B | $3.8B | $3.9B |
| Total liabilities | $1.3B | $1.6B | $1.7B | $1.9B | $1.8B |
| Shareholders' equity | $871M | $995M | $1.3B | $1.9B | $2.1B |
| Net debt (β = net cash) | β$795M | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$2.8M
4 insiders
Sold, 12 months
$11.7M
2 insiders
Of sales under plans
100%
$11.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $239.57 | $2.0M | Form 4 |
| Sep 15, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $245.64 | $2.1M | Form 4 |
| Aug 18, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $219.50 | $1.9M | Form 4 |
| Aug 10, 2026 | Gerald DischlerDirector | Bought | 925 | $215.93 | $0.2M | Form 4 |
| Aug 4, 2026 | Erika Ashley FisherChief Legal Officer | Sold plan | 702 | $235.22 | $0.2M | Form 4 |
| Jul 21, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $221.09 | $1.9M | Form 4 |
| Jun 16, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $184.42 | $1.6M | Form 4 |
| May 19, 2026 | Brian HalliganDirector | Sold plan | 8,500 | $220.00 | $1.9M | Form 4 |
| May 12, 2026 | Dharmesh ShahChief Technology Officer, Director | Bought | 10,000 | $181.37 | $1.8M | Form 4 |
| May 12, 2026 | Yamini RanganChief Executive Officer & Pres, Director | Bought | 2,750 | $189.84 | $0.5M | Form 4 |
| May 11, 2026 | Lorrie M NorringtonDirector | Bought | 1,313 | $190.42 | $0.3M | Form 4 |
| May 4, 2026 | Erika Ashley FisherChief Legal Officer | Sold plan | 915 | $236.66 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β18.4% | β17.3% | β18.7% |
| Altman Z'' | 1.50 | 2.09 | 2.26 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| HubSpot HUBS | $13.7B | 19.2% | 0.2% | 22.6% | β | 96.4x | β | |
| Docusign DOCU | $16.5B | 8.2% | 9.3% | 32.9% | 25.4% | 52.0x | 5 | Compare β |
| Okta OKTA | $38.1B | 11.8% | 5.1% | 30.0% | β | 128.3x | 8 | Compare β |
| Datadog DDOG | $100.0B | 27.7% | β1.3% | 29.2% | β | β | 5 | Compare β |
| PTC PTC | $22.3B | 19.2% | 35.9% | 31.3% | 17.4% | 18.9x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $271M | $376M | $513M | $675M | $883M | $1.3B | $1.7B | $2.2B | $2.6B | $3.1B |
| Gross profit | $209M | $300M | $413M | $545M | $716M | $1.0B | $1.4B | $1.8B | $2.2B | $2.6B |
| Research and development | $46.0M | $70.4M | $118M | $158M | $206M | $302M | $442M | $618M | $779M | $906M |
| Operating income | β$44.7M | β$40.1M | β$48.3M | β$47.0M | β$50.8M | β$54.8M | β$103M | β$201M | β$67.6M | $7.4M |
| Interest expense | $0.3M | $13.2M | $21.4M | $22.8M | $37.0M | $30.3M | $3.8M | $3.8M | $3.7M | $0.9M |
| Pretax income | β$45.0M | β$50.0M | β$62.0M | β$50.8M | β$80.8M | β$73.8M | β$98.5M | β$151M | $28.7M | $69.5M |
| Income tax | $0.5M | β$10.3M | $1.9M | $3.0M | $4.2M | $4.0M | $8.9M | $13.9M | $24.0M | $23.6M |
| Net income | β$45.6M | β$39.7M | β$63.8M | β$53.7M | β$85.0M | β$77.8M | β$107M | β$165M | $4.6M | $45.9M |
| Diluted EPS | β$1.29 | β$1.08 | β$1.66 | β$1.28 | β$1.90 | β$1.66 | β$2.23 | β$3.30 | $0.09 | $0.86 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $19.4M | $49.6M | $84.9M | $119M | $88.9M | $239M | $273M | $351M | $599M | $761M |
| Capital expenditure | $15.8M | $20.3M | $22.3M | $40.4M | $37.3M | $28.7M | $37.4M | $33.7M | $37.9M | $53.2M |
| Free cash flow | $3.6M | $29.3M | $62.6M | $78.6M | $51.6M | $210M | $236M | $317M | $561M | $708M |
| Depreciation and amortization | $11.2M | $15.8M | $23.4M | $28.8M | $37.1M | $45.2M | $58.1M | $72.7M | $96.8M | $136M |
| Stock-based compensation | $32.7M | $47.3M | $76.3M | $97.8M | $122M | $167M | $276M | $432M | $505M | $528M |
| Acquisitions | $0.0M | $9.4M | $0.0M | $23.3M | $0.0M | $16.8M | $0.0M | $142M | $40.4M | $87.6M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $500M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $500M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $114M | $504M | $592M | $962M | $1.3B | $1.2B | $1.4B | $1.4B | $2.1B | $1.7B |
| Total debt | β | $298M | $319M | $341M | $479M | $403M | β | β | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $176M | $603M | $712M | $1.1B | $1.5B | $1.5B | $1.8B | $1.9B | $2.6B | $2.4B |
| Current liabilities | $127M | $178M | $237M | $323M | $446M | $618M | $755M | $942M | $1.6B | $1.5B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $30.2M | $43.3M | $52.5M | $83.6M | $101M | $96.1M | $105M | $103M | $114M | $142M |
| Total assets | $260M | $712M | $834M | $1.6B | $2.0B | $2.2B | $2.5B | $3.1B | $3.8B | $3.9B |
| Total liabilities | $141M | $502M | $589M | $919M | $1.2B | $1.3B | $1.6B | $1.7B | $1.9B | $1.8B |
| Shareholders' equity | $119M | $210M | $245M | $650M | $763M | $871M | $995M | $1.3B | $1.9B | $2.1B |
| Margins | ||||||||||
| Gross margin | 77.2% | 79.8% | 80.4% | 80.7% | 81.1% | 80.1% | 82.2% | 84.4% | 85.0% | 83.8% |
| Operating margin | β16.5% | β10.7% | β9.4% | β7.0% | β5.8% | β4.2% | β5.9% | β9.3% | β2.6% | 0.2% |
| EBITDA margin | β12.4% | β6.5% | β4.8% | β2.7% | β1.6% | β0.7% | β2.6% | β5.9% | 1.1% | 4.6% |
| Net margin | β16.8% | β10.6% | β12.4% | β8.0% | β9.6% | β6.0% | β6.2% | β7.6% | 0.2% | 1.5% |
| FCF margin | 1.3% | 7.8% | 12.2% | 11.7% | 5.9% | 16.2% | 13.6% | 14.6% | 21.3% | 22.6% |
| Returns | ||||||||||
| Return on capital employed | β34.2% | β12.1% | β8.5% | β5.1% | β3.7% | β3.6% | β6.2% | β10.3% | β3.1% | 0.3% |
| Return on equity | β37.9% | β24.1% | β28.1% | β12.0% | β12.0% | β9.5% | β11.5% | β14.1% | 0.3% | 2.3% |
| Return on assets | β19.0% | β8.2% | β8.3% | β4.5% | β4.8% | β3.8% | β4.6% | β5.9% | 0.1% | 1.2% |
| Growth | ||||||||||
| Revenue growth | 48.9% | 38.6% | 36.6% | 31.6% | 30.9% | 47.3% | 33.1% | 25.4% | 21.1% | 19.2% |
| Net income growth | β | β | β | β | β | β | β | β | β | 892.0% |
| EPS growth | β | β | β | β | β | β | β | β | β | 855.6% |
| FCF growth | β | 720.2% | 113.2% | 25.7% | β34.3% | 306.7% | 12.3% | 34.6% | 76.7% | 26.2% |
| Share count change | 5.9% | 4.6% | 4.6% | 9.1% | 6.5% | 4.8% | 2.5% | 3.8% | 3.9% | 2.7% |
| Financial health | ||||||||||
| Debt / equity | β | 1.4x | 1.3x | 0.5x | 0.6x | 0.5x | β | β | β | β |
| Interest coverage | β168.5x | β3.0x | β2.3x | β2.1x | β1.4x | β1.8x | β27.3x | β52.9x | β18.2x | 8.4x |
| Current ratio | 1.4x | 3.4x | 3.0x | 3.4x | 3.3x | 2.4x | 2.3x | 2.0x | 1.7x | 1.7x |
| Quick ratio | 1.4x | 3.4x | 3.0x | 3.4x | 3.3x | 2.4x | 2.3x | 2.0x | 1.7x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.8% | 5.4% | 4.4% | 6.0% | 4.2% | 2.2% | 2.2% | 1.6% | 1.4% | 1.7% |
| Stock comp / revenue | 12.1% | 12.6% | 14.9% | 14.5% | 13.8% | 12.8% | 15.9% | 19.9% | 19.2% | 16.9% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 70.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 5.0 | 7.0 | 5.0 | 5.0 | β | β | β | β |
| Altman Z'' | β2.1 | 2.7 | 2.4 | 3.0 | 3.1 | 2.2 | 2.2 | 1.5 | 2.1 | 2.3 |
| Accruals ratio | β27.1% | β18.4% | β19.2% | β14.4% | β9.8% | β15.3% | β16.1% | β18.4% | β17.3% | β18.7% |
Source: SEC EDGAR XBRL filings (CIK 0001404655). Data updated October 11, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.